# Do GLP-1 Drugs Raise the Risk of Gallbladder Problems? | Buy This GLP

See how often gallstones occurred in randomized GLP-1 trials, what a diabetes cohort found about surgery, and which symptoms warrant prompt care.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Do GLP-1 Drugs Raise the Risk of Gallbladder Problems?

Randomized trials found about two extra gallstone cases per 1,000 people. A diabetes cohort also tracked gallbladder inflammation and surgery.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Adjusted odds against matched controls · at 2 years · at 3 years · gallbladder or bile duct stones · 1.44 · 1.43 · cholecystitis · not significant · 1.45 · gallbladder removal · not significant · 1.54 · pancreatitis · not significant · not significant · 39,140 people in each matched group

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   Across 55 randomized trials, about two additional people per 1,000 had gallstones on a GLP-1 drug compared with placebo.
-   A separate study of adults with type 2 diabetes found higher odds of stones in the gallbladder or bile duct at two and three years.
-   Gallbladder removal was uncommon in both groups. The study found a statistically significant difference at the three-year assessment.

GLP-1 drugs can increase the risk of gallstones. The analysis of [gallstones and reflux in 55 randomized trials](https://buythisglp.com/research/glp1-gallstones-and-reflux-pooled) estimated a gallstone risk ratio of 1.46 (95% CI 1.09–1.97), or about two extra cases per 1,000 people compared with placebo.[\[2\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-2)

## What the diabetes cohort found

Researchers matched 39,140 GLP-1 users with 39,140 controls, all adults with type 2 diabetes. At two years, stones in the gallbladder or bile duct were recorded in 440 users (1.13%) and 307 controls (0.79%). The adjusted odds ratio was 1.44 (95% CI 1.24–1.65). At three years it was 1.43 (95% CI 1.24–1.63). Gallbladder inflammation also had higher adjusted odds at three years (1.45, 95% CI 1.14–1.83).[\[1\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-1)

Participants taking GLP-1 drugs had more abdominal imaging, which may have led to more diagnoses of otherwise unnoticed stones. The groups also differed in baseline BMI despite matching. The randomized trials and the cohort both found an increase in stone diagnoses, each with its own population and measure.[\[1\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-1)[\[2\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-2)

## What the study found about surgery

At two years, gallbladder removal had an adjusted odds ratio of 1.13 (95% CI 0.84–1.54). At three years, 134 GLP-1 users and 87 controls had undergone removal (adjusted odds ratio 1.54, 95% CI 1.17–2.02). Those assessments show when the difference was detectable in this study. They cannot establish when a medication-related risk begins.[\[1\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-1)

Acute pancreatitis and endoscopic bile-duct procedures showed no statistically significant difference at either assessment. Research on [GLP-1 use after an episode of pancreatitis](https://buythisglp.com/research/can-you-take-a-glp1-after-pancreatitis) addresses a separate question about recurrence. Comparisons by drug in the gallbladder cohort also cannot establish which medication is safest.[\[1\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-1)

When symptoms need prompt care

The Zepbound label warns about acute gallbladder disease. NIDDK advises seeking care right away for possible gallstone symptoms, such as abdominal pain lasting several hours, vomiting, fever or chills, or yellowing of the skin or eyes.[\[3\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-3)[\[4\]](https://buythisglp.com/research/do-glp1-drugs-cause-gallbladder-problems#ref-4)

## Frequently asked

How much does gallstone risk rise on a GLP-1?

A review of 55 randomized trials estimated about two additional gallstone cases per 1,000 people compared with placebo. The estimate reflects the participants and follow-up periods in those trials.

Did GLP-1 users have more gallbladder surgery?

In one matched study of adults with type 2 diabetes, 134 GLP-1 users and 87 controls in groups of 39,140 had gallbladder removal by three years. The difference at two years was statistically uncertain.

## Sources

1.  \[1\] Eldesouki MH, et al. (2026). Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes United European Gastroenterology Journal. [PMID 42247589](https://onlinelibrary.wiley.com/doi/10.1002/ueg2.70238)
2.  \[2\] Chiang CH, et al. (2025). Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis Gastroenterology. [PMID 40499738](https://pubmed.ncbi.nlm.nih.gov/40499738/)
3.  \[3\] Eli Lilly and Company (2026). Zepbound prescribing information, section 5.4 DailyMed. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
4.  \[4\] National Institute of Diabetes and Digestive and Kidney Diseases (2017). Symptoms & Causes of Gallstones NIDDK. [Source](https://www.niddk.nih.gov/health-information/digestive-diseases/gallstones/symptoms-causes)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
